Humoral immune response against OKT3.
Chatenoud
L
L
Inserm U25, Hôpital Necker, Paris, France.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D000917:Antibody Formation; D015703:Antigens, CD / Q000032:analysis; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D051379:Mice; D016853:Muromonab-CD3 / Q000276:immunology* / Q000627:therapeutic use; D010865:Pilot Projects; D016176:T-Lymphocyte Subsets / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D000305:Adrenal Cortex Hormones; D015703:Antigens, CD; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine